
Solskin
Novartis (NYSE:NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year.
During a CNBC interview, Narasimhan emphasized the company’s strong fundamentals, pointing to 10 consecutive quarters of raised guidance and